Sezer, MuratAtici, AdemCoskun, IsaCizgici, YasarOzcan, AlpUmman, BerrinBugra, ZehraOzcan, IlkeHasdemir, HakanKocaaga, MehmetDavies, Justin E.Umman, Sabahattin2023-02-212023-02-212020-01-0110.1161/JAHA.119.014804https://hdl.handle.net/11443/1914http://dx.doi.org/10.1161/JAHA.119.014804BACKGROUND: The extent of pressure-related damage might be related to acceleration rate of the applied pressure (peak dP/dt) in the vascular system. In this study, we sought to determine whether dP/dt applied to the aortic wall (aortic dP/dt) and in turn vascular extracellular matrix degradation can be mitigated via modulation of left ventricular (LV) contractility (LV dP/dt) by pacemaker-mediated desynchronization. METHODS AND RESULTS: First, in 34 patients, changes in aortic dP/dt values in 3 aortic segments in response to pacemaker-mediated stepwise QRS widening leading to gradual desynchronization of the LV contraction by means of steadily changed atrioventricular delay (AVD) with temporary dual-chamber pacing was examined before and after beta-blocker (15 mg IV metoprolol) administration. Second, serum matrix metalloproteinase-9 levels were measured in the 20 patients with permanent pacemaker while they were on sinus rhythm with normal QRS width and 3 weeks after wide QRS rhythm ensured by dual pacing, dual sensing, and dual response to sensing with short AVD. LV dP/dt substantially correlated with dP/dt measured in ascending (r=0.83), descending (r=0.89), and abdominal aorta (r=0.96). QRS width strongly correlated with dP/dt measured in ascending (r=-0.95), descending (r=-0.92), and abdominal (r=-0.96) aortic segments as well. In patients with permanent pacemaker, wide QRS rhythm led to a significant reduction in serum matrix metalloproteinase-9 levels (from 142.5 +/- 32.9 pg/mL to 87.5 +/- 32.4 pg/mL {[}P<0.001]) at the end of 3 weeks follow-up. CONCLUSIONS: QRS prolongation by short AVD dual pacing, dual sensing, and dual response to sensing results in concomitant decreases in peak dP/dt values in the LV and in all aortic segments with or without background beta-blocker administration, which in turn led to a significant reduction in circulating matrix metalloproteinase-9 levels.aortic aneurysmdP/dtmatrix metalloproteinasespacingArticleWOS:000550987100022